Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterodimeric antibodies that bind CD3 and PSMA

Heterodimeric antibodies that bind CD3 and PSMA

US Patent 11623957 · Granted Apr 11, 2023

Estimated economic value: $16,675,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
Heterodimeric human IgG1 polypeptides with isoelectric point modifications2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Heterodimeric proteins2025
Heterodimeric proteins2025
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and2025
Heterodimeric antibodies that bind CD3 and CLDN62025